Status:
COMPLETED
Creatine Supplementation in Autism Spectrum Disorder
Lead Sponsor:
University of Novi Sad, Faculty of Sport and Physical Education
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Autism Spectrum Disorder (ASD) is accompanied by reduced levels of total creatine in right temporal-parietal junction and other brain regions of interest, and addressing this deficit by exogenous admi...
Eligibility Criteria
Inclusion
- Age 10 years and above
- Informed consent signed by a parent or legal guardian or legal representative
- Diagnostic and Statistical Manual of Mental Disorders-IV criteria for ASD.
Exclusion
- Pregnant or nursing female patients
- Non-pharmacologic therapy
- Current diagnosis of other mental disorder
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04498078
Start Date
January 15 2022
End Date
May 2 2025
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FSPE Applied Bioenergetics Lab
Novi Sad, Vojvodina, Serbia, 21000